Cover Image
市場調查報告書

藥物、設備組合產品的全球市場 (2015∼2019年)

Global Drug Device Combination Products Market 2015-2019

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 345165
出版日期 內容資訊 英文 74 Pages
訂單完成後即時交付
價格
Back to Top
藥物、設備組合產品的全球市場 (2015∼2019年) Global Drug Device Combination Products Market 2015-2019
出版日期: 2015年11月11日 內容資訊: 英文 74 Pages
簡介

所謂藥物、設備組合產品,是從醫藥品原料藥 (API) 和醫療設備這2種受限的產品組成,將這些以化學物理性組合,構成一個產品。那時,將藥效成分滲入內部,或塗於表面。生物醫療用奈米技術和再生醫療的開發的領域,藥物、設備組合產品非常創新的技術。全球藥物、設備組合產品市場2014∼2019年,以11.95%的年複合成長率(CAGR) 成長。

本報告提供全球藥物、設備組合產品的市場相關分析、市場概要和結構、市場規模趨勢 (今後5年的預測值)、各產品/各地區的詳細趨勢、推動&阻礙市場要素與其影響力、主要企業簡介、今後的市場機會等調查評估。

第1章 摘要整理

  • 分析結果的概要

第2章 分析範圍

  • 分析概要
  • 大供應商的主要產品

第3章 市場分析技術

  • 分析方法
  • 經濟指標

第4章 簡介

  • 市場趨勢的概要

第5章 市場環境

  • 市場概要
  • 市場規模與其預測
  • 波特的五力分析

第6章 各產品的市場區隔

  • 藥劑溶出性血管支架
  • 預填充式注射器
  • 穿戴式注射器
  • 胰島素給藥裝置

第7章 地區區分

  • 全球藥物、設備組合產品市場:各地區的明細
  • 南北美洲市場
  • 歐洲、中東、非洲地區 (EMEA) 市場
  • 亞太地區市場

第8章 推動市場要素

第9章 推動因素的影響力

第10章 市場課題

第11章 推動因素、課題的影響力

第12章 市場趨勢

第13章 供應商環境

  • 競爭方案
  • 市場佔有率分析
  • 其他卓越供應商

第14章 主要供應商分析

  • Abbott Diagnostics
  • Becton, Dickinson and Company
  • Boston Scientific
  • Medtronic
  • Roche Diagnostics

第15章 附錄

  • 簡稱集

第16章 關於Technavio

圖表一覽

目錄
Product Code: IRTNTR7796

About drug device combination products

Drug device combination products consist of two regulated components: an active pharmaceutical ingredient and a medical device. These two standardized components are combined, either chemically or physically for developing one component. The drugs present in the device are either impregnated or surface coated. The drug device combination products are considered to be highly innovative in the area of advanced healthcare such as biomedical nanotechnology and development of regenerative medicine.

Technavio's analysts forecast the global drug device combination products market to grow at a CAGR of 11.95% over the period 2014-2019.

Covered in this report

The report includes the present scenario and the growth prospects of the global drug device combination products market for 2015-2019. The market can be segmented by product type:

  • Drug eluting stent
  • Prefilled syringes
  • Wearable injectors
  • Insulin delivery systems

Technavio's report, Global Drug Device Combination Products Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global drug device combination products market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions

  • Americas
  • APAC
  • EMEA

Key vendors

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Boston Scientific
  • Medtronic
  • Roche Diagnostics

Other Prominent Vendors

  • Aerogen
  • Airon
  • Allied Healthcare Products
  • AstraZeneca
  • B. Braun Medical
  • BIOTRONIK
  • Boehringer Ingelheim
  • Briggs Healthcare
  • C.R. Bard
  • Cardinal Health
  • Clement Clarke International
  • Concordia
  • Consort Medical
  • Cook Medical
  • DeVilbiss Healthcare
  • Ethicon
  • Gerresheimer
  • GlaxoSmithKline
  • Heyer Medical
  • Invacare
  • Lepu Medical Technology
  • Mallinckrodt
  • Medline Industries
  • MicroPort Scientific
  • Mylan
  • Nypro
  • Omron Healthcare
  • PARI Medical
  • Phillips Healthcare
  • RPC Bramlage
  • Salter Labs
  • Smart inhaler
  • Stryker
  • Sunovion Pharmaceuticals
  • Teleflex
  • Terumo
  • Vortran Medical
  • W. L. Gore & Associates

Key market driver

  • Use of home healthcare devices
  • For a full, detailed list, view our report

Key market challenge

  • High spending by patients
  • For a full, detailed list, view our report

Key market trend

  • Use of bioabsorable stents
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Offerings of the top vendors

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Market segmentation by product

  • Drug-eluting stents
  • Prefilled syringes
  • Wearable injectors
  • Insulin delivery systems

PART 07: Geographical segmentation

  • Global drug device combination products market by geographical segmentation
  • Drug device combination products market in Americas
  • Drug device combination products market in EMEA
  • Drug device combination products market in APAC

PART 08: Market drivers

PART 09: Impact of drivers

PART 10: Market challenges

PART 11: Impact of drivers and challenges

PART 12: Market trends

PART 13: Vendor landscape

  • Competitive scenario
  • Market share analysis 2014
  • Other prominent vendors

PART 14: Key vendor analysis

  • Abbott Diagnostics
  • Becton, Dickinson and Company
  • Boston Scientific
  • Medtronic
  • Roche Diagnostics

PART 15: Appendix

  • List of abbreviations

PART 16: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Global drug device combination products market
  • Exhibit 03: Global drug device combination products market 2014-2019 ($ billions)
  • Exhibit 04: Five forces analysis
  • Exhibit 05: Segmentation of global drug device combination products market by product type
  • Exhibit 06: Segmentation of global drug device combination products market by product type 2014
  • Exhibit 07: Segmentation of global drug device combination products market by product type 2019
  • Exhibit 08: Segmentation of global drug device combination products market by product type 2014-2019
  • Exhibit 09: Global drug device combination products market in drug-eluting stent segment 2014-2019 ($ billions)
  • Exhibit 10: Global drug device combination products market in prefilled syringe segment 2014-2019 ($ billions)
  • Exhibit 11: Global drug device combination products market in wearable injector segment 2014-2019 ($ billions)
  • Exhibit 12: Global drug device combination products market in insulin delivery system segment 2014-2019 ($ billions)
  • Exhibit 13: Segmentation of global drug device combination products market by geography 2014
  • Exhibit 14: Segmentation of global drug device combination products market by geography 2019
  • Exhibit 15: Segmentation of global drug device combination products market by geography 2014-2019
  • Exhibit 16: Drug device combination products market in Americas 2014-2019 ($ billions)
  • Exhibit 17: Diseases and mortality in Europe 2011
  • Exhibit 18: Drug device combination products market in EMEA 2014-2019 ($ billions)
  • Exhibit 19: Drug device combination products market in APAC 2014-2019 ($ billions)
  • Exhibit 20: Impact of drivers
  • Exhibit 21: Impact of drivers and challenges
  • Exhibit 22: Companies developing bioabsorbable drug-eluting stents
  • Exhibit 23: Abbott Diagnostics: Key takeaways
  • Exhibit 24: BD: Key takeaways
  • Exhibit 25: Boston Scientific: Key takeaways
  • Exhibit 26: Medtronic: Key takeaways
  • Exhibit 27: Roche Diagnostics: Key takeaways
  • Exhibit 28: BD: Business segmentation 2014 by revenue
  • Exhibit 29: BD: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 30: BD: Geographical segmentation by revenue 2014
  • Exhibit 31: Boston Scientific: Business segmentation by revenue 2014
  • Exhibit 32: Boston Scientific: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 33: Medtronic: Business segmentation by revenue 2015
  • Exhibit 34: Roche Diagnostics: Business segmentation by revenue 2014
  • Exhibit 35: Roche Diagnostics: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 36: Roche Diagnostics: Geographical segmentation by revenue 2014
Back to Top